Cardiovascular Risk in Patients with HIV Infection

This publication has 100 references indexed in Scilit:

• Tipranavir
  Drugs, 2005
• Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
  American Heart Journal, 2004
• Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
  European Journal of Clinical Microbiology & Infectious Diseases, 2004
• Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized Trial
  JAMA, 2004
• Association of hypocholesterolaemia with hepatitis C virus infection in HIV‐infected people^*
  HIV Medicine, 2004
• Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Na ve and HIV-Negative Controls: Results from a Norwegian Study of 721 Patients
  European Journal of Clinical Microbiology & Infectious Diseases, 2003
• Interactions Between Antiretroviral Drugs and Drugs Used for the Therapy of the Metabolic Complications Encountered During HIV Infection
  Clinical Pharmacokinetics, 2002
• Recreational drug misuse: issues for the cardiologist
  Heart, 2000
• Cardiovascular disease risk profiles
  American Heart Journal, 1991
• Prediction of Creatinine Clearance from Serum Creatinine
  Nephron, 1976